These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7488142)

  • 1. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
    Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
    Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.
    Harris TE; Albrecht JH; Nakanishi M; Darlington GJ
    J Biol Chem; 2001 Aug; 276(31):29200-9. PubMed ID: 11369759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
    Adams PD; Sellers WR; Sharma SK; Wu AD; Nalin CM; Kaelin WG
    Mol Cell Biol; 1996 Dec; 16(12):6623-33. PubMed ID: 8943316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
    Kaldis P; Cheng A; Solomon MJ
    J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characterization of human cdc2 kinase and CDK2].
    Yasuda H; Kamijo M; Ohba Y
    Yakugaku Zasshi; 1993 Dec; 113(12):829-46. PubMed ID: 8301538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.
    Holmes JK; Solomon MJ
    J Biol Chem; 1996 Oct; 271(41):25240-6. PubMed ID: 8810285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
    Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cdk2 binding domain of p27Kip correlates with the inhibition of the kinase activity of cdk2/cyclin complexes.
    Kwon TK; Buchholz MA; Nordin AA
    Biochem Biophys Res Commun; 1996 Mar; 220(3):703-9. PubMed ID: 8607829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
    Connell-Crowley L; Solomon MJ; Wei N; Harper JW
    Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of mammalian cyclin-dependent kinase 2.
    Sheaff RJ
    Methods Enzymol; 1997; 283():173-93. PubMed ID: 9251019
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
    Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
    Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
    Pan ZQ; Amin A; Hurwitz J
    J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2.
    Desai D; Wessling HC; Fisher RP; Morgan DO
    Mol Cell Biol; 1995 Jan; 15(1):345-50. PubMed ID: 7799941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ik3-1/Cables is a substrate for cyclin-dependent kinase 3 (cdk 3).
    Yamochi T; Semba K; Tsuji K; Mizumoto K; Sato H; Matsuura Y; Nishimoto I; Matsuoka M
    Eur J Biochem; 2001 Dec; 268(23):6076-82. PubMed ID: 11733001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.